Nadim Ahmed - 25 Feb 2025 Form 4 Insider Report for Cullinan Therapeutics, Inc. (CGEM)

Role
President and CEO, Director
Signature
/s/ Jacquelyn Sumer, Attorney-in-Fact
Issuer symbol
CGEM
Transactions as of
25 Feb 2025
Transactions value $
-$106,872
Form type
4
Date filed
27 Feb 2025, 17:00
Previous filing
21 Feb 2025
Next filing
16 Jul 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CGEM Common Stock Sale -$107K -12.5K -2.83% $8.53 431K 25 Feb 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Sale of shares to cover personal income tax obligations upon vesting of restricted stock units.